Trace/s,” an exhibition at the Center for Brooklyn History, highlights the borough’s neglected story of slavery — and the Black genealogists helping to unearth it.

On Dec. 5, Eli Lilly and Company unveiled plans for a $3 billion expansion of its manufacturing operations in Kenosha County, expected to create 750 family ... Christmas tree lighting Nov. 30 ...

Shares of Eli Lilly & Co. were headed for their worst day in nearly four years on Tuesday after the drugmaker provided a fourth-quarter revenue outlook that was below expectations, citing slower ...

Eli Lilly has announced plans to acquire Scorpion Therapeutics’ PI3Kα inhibitor program. Credit: Michael Vi via Shutterstock. Eli Lilly will buy Boston biotech Scorpion Therapeutics’ PI3Kα inhibitor ...

After the family of Grayson Roberts, a 10-year-old Southern California boy who is blind due to a rare genetic eye condition, lost their home to the Eaton Fire, community members are coming together to ...

The company only reported Q3 revenues of $11.44 billion, and the guidance for Q4 was a very aggressive revenue target of $13.9 billion. Eli Lilly only reached revenues of $13.5 billion ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stocks. In one of his latest appearances on CNBC's Squawk on the Street, Jim Cramer ...

Eli Lilly forecasts $45 billion in 2024 revenue ... Get the Real Story Behind Every Major Earnings Report The company's expected 2024 revenue is $400 million, or about 3%, below the guidance ...

The product, family-sized, 48-ounce cartons of Great Value Chicken Broth, are sold in aseptic paper cartons that could “compromise the sterility of the product, resulting in spoilage,” according to an ...

Shares of Eli Lilly have been falling in recent months, but that could spell opportunity. Investors appear to be concerned that a new government could impact its growth potential. The business is ...

Eli Lilly announced preliminary fourth-quarter revenue of roughly $13.5 billion, or $400 million below the low end of its guidance, driven by slower-than-expected US market growth and lower ...

Eli Lilly shares climbed 32% last year but have slumped more than 16% since October after the company reported third quarter sales of the two drugs below Wall Street’s expectations, prompting ...